Clinical trial support C3 has supported 20+ FDA clinical trials, indicating strong regulatory readiness and a proven track record that can be leveraged to expand collaboration with sponsors seeking reliable aseptic manufacturing, cell culture, and purification capabilities.

Broad service scope Offerings span therapeutic cell therapy, diagnostics, genomic work, animal health, and food safety research, suggesting cross-selling opportunities to existing clients in adjacent biotech sectors and opportunities to upsell integrated manufacturing and analytics services.

Regulated facilities Operating manufacturing, regulated clean rooms, and a distribution center in Minneapolis positions the company to attract clients requiring compliant end-to-end supply chains, quality control, and timely global distribution.

Growth and capacity Revenue indicates a growing mid-market biotech player; with 11-50 employees, there is potential to scale partnerships that require additional GMP capabilities, bioreactor manufacturing, and enhanced analytics to support larger programs.

Global lab footprint Serving 1,700+ global laboratories suggests a ready-made network for expanding trial sites, reference labs, or training partnerships, enabling introductions to enterprise clients seeking broad laboratory support and standardization.